The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IO
about
Beneficial Effects of UV-Radiation: Vitamin D and beyondOsteoporosis and sarcopenia: two diseases or one?Effect of Low-Dose Vitamin D Supplementation on Serum 25(OH)D in School Children and White-Collar WorkersOral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A "Real-Life" StudyAssociation between Obesity and Serum 25(OH)D Concentrations in Older Mexican Adults.CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health.Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology.Oral calcidiol is a good form of vitamin D supplementation.Nonspecific binding of a frequently used vitamin D receptor (VDR) antibody: important implications for vitamin D research in human health.Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.25(OH)D3-enriched or fortified foods are more efficient at tackling inadequate vitamin D status than vitamin D3.Sunscreens block cutaneous vitamin D production with only a minimal effect on circulating 25-hydroxyvitamin D.Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults.
P2860
Q28079688-1A8B33DD-2450-4851-B37F-8E4EB2774F37Q28081505-A8DC40E0-88B8-4D43-BD84-48971C190964Q33749542-B3CAE673-837B-42AA-A532-C4D5BF548911Q35739579-7B134753-7055-4538-A81D-356C5CA6FA1DQ37673112-70D87BB4-112B-4093-8F32-EF2F1F071A58Q39247900-8366F767-3D6A-470B-B84C-34D20A6FB49FQ47117629-329222BF-F584-44D3-8AB0-2E71FE9A391CQ47150354-B815DE86-947E-4215-BE50-33E4A843C4BDQ48273831-0B7FAA97-DB77-476D-AF1F-2B4DA81EE6F2Q48577052-4C6E4E80-6B16-45A9-B527-B026EA8DF81CQ49662255-55BA5D9D-3D7D-4640-905D-C338B50D5812Q50247350-BEEDB37A-164C-4C4C-8F33-B5D3C0DC1E24Q54965822-F1844E8E-74A1-4397-9B53-BE515A3C88E4
P2860
The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IO
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The clinical use of vitamin D ...... al Osteoporosis Foundation (IO
@en
type
label
The clinical use of vitamin D ...... al Osteoporosis Foundation (IO
@en
prefLabel
The clinical use of vitamin D ...... al Osteoporosis Foundation (IO
@en
P2093
P2860
P1433
P1476
The clinical use of vitamin D ...... al Osteoporosis Foundation (IO
@en
P2093
Claudio Cricelli
Jean-Y Reginster
Johann D Ringe
John A Kanis
Luisella Cianferotti
Maria Luisa Brandi
Ranuccio Nuti
Rene Rizzoli
P2860
P2888
P356
10.1007/S12020-015-0606-X
P577
2015-05-01T00:00:00Z